eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-PCVX-Vaxcyte Inc

Vaxcyte Inc PCVX

$32.361.48(4.78%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Vaxcyte Inc
Today
Create an eToro account to buy PCVX stock on a secure, user-friendly, multi-asset trading platform.
Buy Vaxcyte Inc
Buy Vaxcyte Inc
Vaxcyte Inc PCVX
Buy PCVX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
88.67
Based on analysts who covered PCVX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Vaxcyte Inc News

More about Vaxcyte Inc
Vaxcyte Inc is an American biotechnology and pharmaceutical company based in Foster City, California. Founded in 2013, the firm is primarily engaged in the development of potentially superior and novel vaccines for a variety of infectious diseases. It aims to serve the healthcare community and patients worldwide, helping to prevent and treat some of the most common deadly diseases.

The firm trades on the NASDAQ GS where its stock is listed under the ticker PCVX. In December 2020 the PCVX price chart was showing a 52 week high of $58.48 and a 52 week low of $17.80, with a market cap of $1.55bn.

The company's lead programme is a board-spectrum pneumococcal conjugate vaccine (PCV) which is designed to provide expanded protection for patients, against currently circulating strains of pneumococcus. Other vaccines in the pipeline are being designed to protect against Invasive Pneumococcal Disease, Otitis Media, Group A Strep Infections and Periodontitis. The company is developing novel vaccines and vaccines that are potentially more effective than those currently available to help prevent and treat disease in millions of people across the globe.

Consider diversifying your investments today by adding PCVX stock to your eToro portfolio, or track this instrument via your watchlist.
VIEW MORE   

PCVX Stock Price Chart

‎-2.27‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Vaxcyte Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Vaxcyte Inc price today is $32.36, a ‎4.78‎% change in the last 24 hours and ‎-3.63‎% in the past week. Vaxcyte Inc price changed by ‎-72.35‎% in the past year.
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-
Day’s Range
i
Shows the high and low prices of the day.
$31.29 - $32.19
52W Range
i
Shows the high and low prices of the last year.
$27.59 - $120.7
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-
Revenue
i
The total income generated by this company’s goods and services last year.
-
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-
Prev Close
i
The final price of this asset at the end of the last trading day.
$30.89
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-
What Is Vaxcyte Inc?
Vaxcyte Inc is an American biotechnology and pharmaceutical company based in Foster City, California. Founded in 2013, the firm is primarily engaged in the development of potentially superior and novel vaccines for a variety of infectious diseases. It aims to serve the healthcare community and patients worldwide, helping to prevent and treat some of the most common deadly diseases.

The firm trades on the NASDAQ GS where its stock is listed under the ticker PCVX. In December 2020 the PCVX price chart was showing a 52 week high of $58.48 and a 52 week low of $17.80, with a market cap of $1.55bn.

The company's lead programme is a board-spectrum pneumococcal conjugate vaccine (PCV) which is designed to provide expanded protection for patients, against currently circulating strains of pneumococcus. Other vaccines in the pipeline are being designed to protect against Invasive Pneumococcal Disease, Otitis Media, Group A Strep Infections and Periodontitis. The company is developing novel vaccines and vaccines that are potentially more effective than those currently available to help prevent and treat disease in millions of people across the globe.

Consider diversifying your investments today by adding PCVX stock to your eToro portfolio, or track this instrument via your watchlist.
CEO
Grant E. Pickering, MBA
Employees
414
Founded
2013
HQ
San Carlos, California, US
Med Tech
NASDAQ
Buy PCVX

How can I buy Vaxcyte Inc stocks?

To purchase Vaxcyte Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Vaxcyte Inc (PCVX) page and place an order to buy Vaxcyte Inc.
Buy PCVX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Vaxcyte Inc
Invest in Vaxcyte Inc
Today
Create an eToro account to buy PCVX stock on a secure, user-friendly, multi-asset trading platform.
Buy PCVX

FAQ

The current price of PCVX is $32.36.
The average price target for Vaxcyte Inc is $88.67. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Vaxcyte Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Vaxcyte Inc is -
Based on 3 analysts offering recommendations for PCVX in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top